HEOR at the Nexus of Policy and Science
Thank you to all who attended ISPOR Europe 2023! If you purchased the Digital Conference Pass, access is available from 5 December 2023 to 9 January 2024 and includes recordings of the educational content from ISPOR Europe 2023, plus exclusive post conference Key Insights, a series of short video segments, that summarize, reflect on, and provide key takeaways from HEOR and policy discussions focused on specific topic areas. Additionally, the final versions of slide presentations will also be available within the ISPOR Presentation Database as well as the ISPOR Europe 2023 Program page beginning 13 December.
Speakers
Head at HTA Strategy and External Engagement | National Centre for Pharmacoeconomics, Dublin, Ireland & Discipline of Pharmacology and Therapeutics, Trinity College Dublin
Advisor, Belgian Council Presidency, Cabinet of the Deputy Prime Minister Frank Vandenbroucke | Belgium Federal Government
Profesor Asociado | Independent Economics Consultant, Universidad Carlos III de Madrid
Advisor, Co-Chair JCA Subgroup under the HTA Coordination Group, Research, Development & International Affairs | National Health Care Institute
Doctoral Researcher | Department of Pharmaceutical and Pharmacological Sciences, KU Leuven
Senior Director, Health Economics and Outcomes Research | Regeneron Pharmaceuticals, Inc
Head of the Real World Evidence (TDA-RWE), Data Analytics and Methods Task Force (TDA) | European Medicines Agency
Chief Executive Officer | European Organisation for Research and Treatment of Cancer (EORTC)
Scientific Adviser | National Institute for Health and Care Excellence (NICE)
Professor, Department of Population Health Sciences | Duke University’s School of Medicine
Professor and Chair | UMIT TIROL-University for Health Sciences and Technology Hall in Tirol, Austria, and Harvard Chan School of Public Health Boston, USA